Provided by Tiger Trade Technology Pte. Ltd.

Intellia Therapeutics

13.07
+0.47003.73%
Post-market: 13.03-0.0400-0.31%19:54 EDT
Volume:8.15M
Turnover:104.68M
Market Cap:1.83B
PE:-3.91
High:13.27
Open:12.36
Low:11.93
Close:12.60
52wk High:28.25
52wk Low:7.95
Shares:140.00M
Float Shares:137.56M
Volume Ratio:1.03
T/O Rate:5.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3456
EPS(LYR):-3.8100
ROE:-55.44%
ROA:-30.14%
PB:2.51
PE(LYR):-3.43

Loading ...

Oct 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2026

Major Issues Report

Form 8-K - Current report
Sep 04, 2026

Major Issues Report

Form 8-K - Current report
Aug 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Major Issues Report

Form 8-K - Current report
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Apr 10, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]